Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Quest Diagnostics
 More »

  • Clinical Genomics Nabs Enterix, Aims to Launch New Bowel Cancer...
    Australian molecular diagnostics firm Clinical Genomics has acquired U.S.-based cancer screening company Enterix from Quest Diagnostics as well as the Sydney-based subsidiary. ...
    10-8-2013
  • New Gene Patent Suit Sparks Talk of Trolls
    ... BRAC Analysis accounted for 74% of Myriad's total revenue-no small consideration in the company's playing hardball with rivals. GeneDx and Quest Diagnostics have launched their own ...
    7-23-2013
  • Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for...
    Quest Diagnostics today said Royalty Pharma has purchased its rights to royalties from commercialization of cancer candidate ibrutinib in a $485 million all-cash deal. Quest gained ...
    7-18-2013
  • Quest Acquires Concentra's Toxicology, Clinical Lab Business
    Quest Diagnostics today said it has acquired the toxicology and clinical laboratory business of Humana subsidiary Concentra. Further, Quest has agreed to be Concentra's primary ...
    5-16-2013
  • Companion Diagnostics: 52 Pick-Up
    ... PrimeraDx and Quest Diagnostics Agreement announced March 26 Nonexclusive agreement to co-develop and commercialize diagnostics that will apply Primera Dx's ICEPlex System ...
    5-9-2013
  • Layoffs and Breakup at Roche
    of its Applied Science Business Area, which is part of the firm's Diagnostics Division. ... Additionally, Roche has ended of its quest to develop a nanopore-based sequencing platform ...
    4-23-2013
  • Stockholm-Uppsala Region Ups the Ante
    Area Bets Big in Quest for International Renown The ultimate goal of the Stockholm-Uppsala ... Dr. Nilsson, a professor of molecular diagnostics at Uppsala University and a member of ...
    4-15-2013
  • Thermo Fisher's (Mostly) Buying Spree
    Dionex is integrated into Thermo's Laboratory Products and Services segment. February 24, 2011 - Sells its Athena Diagnostics to Quest Diagnostics for $740 million, and its ...
    4-15-2013
  • PrimeraDx on Quest for New Companion Dx
    Molecular diagnostics company PrimeraDx has forged a nonexclusive co-development agreement with diagnostics information services company Quest Diagnostics to co-develop and ...
    3-26-2013
  • Stockholm-Uppsala Region Ups the Ante
    The region bets big in the quest for international renown. Putting neighboring-city ... Dr. Nilsson, a professor of molecular diagnostics at Uppsala University and a member of ...
    3-6-2013
  • Nucleic Acid Sample Preparation in MDx
    ... Jamie Platt, Ph.D., CGMBS, scientific director, molecular microbiology-gene sequencing, infectious diseases, Quest Diagnostics Nichols Institute, and colleagues, developed a ...
    3-1-2013
  • Duke Obtains License to Trovagene's Leukemia Dx
    of NPM1 as a laboratory service for the diagnosis and monitoring of patients with AML to Quest Diagnostics, LabCorp, Fairview Health Services, and Invivoscribe Technologies. ...
    12-27-2012
  • Epigenetics Reshapes the Therapeutic Arena
    ... In the U.S., Epigenomics has licensed its septin 9 methylation technology to Quest Diagnostics, ARUP Laboratories, and Companion Dx. "There are tens of thousands of assays that ...
    12-1-2012
  • Lucky 13 Serial Entrepreneurs
    ... magnetic resonance technology to provide rapid, accurate and portable diagnostics. ... Target Quest -Co-founder. Launched 1997 to apply phage display technology for antibody ...
    11-12-2012
  • Companion Dx and Personalized Medicine
    ... trials-to identify patients likely to benefit. "Recently, Life talked about taking technologies into CLIA labs, and has approached Quest Diagnostics and LabCorp," O'Bryan adds. ...
    11-1-2012

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll